5 Comments

It’s just a matter of time.

Expand full comment

Ozempic is the new soma

Expand full comment

We’ve been waiting for this! It confirms everything we are seeing out in the field with service users, huge reductions in cravings and alcohol consumption. Great to see trials now backing this up with clinical evidence

Expand full comment

The irony here is that it has a patent. NAD+ via IV works better than ozempic, with no side effects and a much longer history of use (since the 1960s) and no recidivism, yet I don’t hear any trumpets for it…

Expand full comment

NAD+ IV is a very interesting treatment, but IVs are not easy to scale as an intervention. Also my understanding is that it potentially helps with withdrawal symptoms but not necessarily for ongoing use and cravings. I totally agree that our medical system disincentivizes research on non-patented interventions-- it's a huge problem.

Expand full comment